| AA0016 Cancer Apoptosis Phospho-Specific Array includes 155 highly specific and well-characterized phosphorylation antibodies in the Cancer Apoptosis pathway. Abnova 2 Pieces/Box 822 |
AA0016 |
Cancer Apoptosis Phospho-Specific Array includes 155 highly specific and well-characterized phosphorylation antibodies in the Cancer Apoptosis pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0015 Apoptosis Phospho-Specific Array includes 247 highly specific and well-characterized phosphorylation antibodies i related to the proteins regulating apoptosis. Abnova 2 Pieces/Box 822 |
AA0015 |
Apoptosis Phospho-Specific Array includes 247 highly specific and well-characterized phosphorylation antibodies i related to the proteins regulating apoptosis. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0002 Apoptosis antibody array includes 73 highly specific and well-characterized antibodies in the apoptosis pathway. Abnova 2 Pieces/Box 731 |
AA0002 |
Apoptosis antibody array includes 73 highly specific and well-characterized antibodies in the apoptosis pathway. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0012 AKT Phospho-Specific Array includes 137 highly specific and well-characterized phosphorylation antibodies in the AKT pathway. Abnova 2 Pieces/Box 776 |
AA0012 |
AKT Phospho-Specific Array includes 137 highly specific and well-characterized phosphorylation antibodies in the AKT pathway. |
Abnova |
2 Pieces/Box |
776€ |
|
Pub |
| AA0013 AKT PKB Signaling Phospho-Specific Array includes 216 highly specific and well-characterized phosphorylation antibodies in the AKT PKB signaling pathway. Abnova 2 Pieces/Box 822 |
AA0013 |
AKT PKB Signaling Phospho-Specific Array includes 216 highly specific and well-characterized phosphorylation antibodies in the AKT PKB signaling pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0014 AMPK Signaling Phospho-Specific Array includes 174 highly specific and well-characterized phosphorylation antibodies in the AMPK signaling pathway. Abnova 2 Pieces/Box 822 |
AA0014 |
AMPK Signaling Phospho-Specific Array includes 174 highly specific and well-characterized phosphorylation antibodies in the AMPK signaling pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0018 Cell Cycle Phospho-Specific Array includes 76 highly specific and well-characterized phosphorylation antibodies in the Cell Cycle pathway. Abnova 2 Pieces/Box 731 |
AA0018 |
Cell Cycle Phospho-Specific Array includes 76 highly specific and well-characterized phosphorylation antibodies in the Cell Cycle pathway. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0019 Chromatin Transcription Phospho-Specific Array includes 173 highly specific and well-characterized phosphorylation antibodies in the Chromatin Transcription pathway. Abnova 2 Pieces/Box 822 |
AA0019 |
Chromatin Transcription Phospho-Specific Array includes 173 highly specific and well-characterized phosphorylation antibodies in the Chromatin Transcription pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0020 CREB Phospho-Specific Array includes 174 highly specific and well-characterized phosphorylation antibodies in the CREB pathway. Abnova 2 Pieces/Box 822 |
AA0020 |
CREB Phospho-Specific Array includes 174 highly specific and well-characterized phosphorylation antibodies in the CREB pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0021 Cytoskeleton Phospho-Specific Array includes 95 highly specific and well-characterized phosphorylation antibodies in the cytoskeletal pathway. Abnova 2 Pieces/Box 731 |
AA0021 |
Cytoskeleton Phospho-Specific Array includes 95 highly specific and well-characterized phosphorylation antibodies in the cytoskeletal pathway. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0022 Cytoskeleton II Phospho-Specific Array includes 141 highly specific and well-characterized phosphorylation antibodies in the cytoskeletal pathway. Abnova 2 Pieces/Box 776 |
AA0022 |
Cytoskeleton II Phospho-Specific Array includes 141 highly specific and well-characterized phosphorylation antibodies in the cytoskeletal pathway. |
Abnova |
2 Pieces/Box |
776€ |
|
Pub |
| AA0024 ErbB Her Signaling Phospho-Specific Array includes 239 highly specific and well-characterized phosphorylation antibodies in the ErbB Her pathway. Abnova 2 Pieces/Box 822 |
AA0024 |
ErbB Her Signaling Phospho-Specific Array includes 239 highly specific and well-characterized phosphorylation antibodies in the ErbB Her pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0025 ERK Signaling Phospho-Specific Array includes 208 highly specific and well-characterized phosphorylation antibodies in the ERK pathway. Abnova 2 Pieces/Box 822 |
AA0025 |
ERK Signaling Phospho-Specific Array includes 208 highly specific and well-characterized phosphorylation antibodies in the ERK pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0027 GPCR Signaling to MAPK ERk Phospho-Specific Array includes 193 highly specific and well-characterized phosphorylation antibodies related to this signaling pathway. Abnova 2 Pieces/Box 822 |
AA0027 |
GPCR Signaling to MAPK ERk Phospho-Specific Array includes 193 highly specific and well-characterized phosphorylation antibodies related to this signaling pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0028 IGF-1R Signaling Phospho-Specific Array includes 245 highly specific and well-characterized phosphorylation antibodies in the insulin-like growth factor 1 receptor signaling pathway. Abnova 2 Pieces/Box 822 |
AA0028 |
IGF-1R Signaling Phospho-Specific Array includes 245 highly specific and well-characterized phosphorylation antibodies in the insulin-like growth factor 1 receptor signaling pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0029 Insulin Receptor Phospho-Specific Array includes 219 highly specific and well-characterized phosphorylation antibodies in the insulin receptor pathway. Abnova 2 Pieces/Box 822 |
AA0029 |
Insulin Receptor Phospho-Specific Array includes 219 highly specific and well-characterized phosphorylation antibodies in the insulin receptor pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0030 Insulin Glucose Phospho-Specific Array includes 85 highly specific and well-characterized phosphorylation antibodies in the insulin glucose pathway. Abnova 2 Pieces/Box 731 |
AA0030 |
Insulin Glucose Phospho-Specific Array includes 85 highly specific and well-characterized phosphorylation antibodies in the insulin glucose pathway. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0031 Jak Stat Phospho-Specific Array includes 42 highly specific and well-characterized phosphorylation antibodies in the Jak Stat pathway. Abnova 2 Pieces/Box 598 |
AA0031 |
Jak Stat Phospho-Specific Array includes 42 highly specific and well-characterized phosphorylation antibodies in the Jak Stat pathway. |
Abnova |
2 Pieces/Box |
598€ |
|
Pub |
| AA0032 Jak Stat II Phospho-Specific Array includes 202 highly specific and well-characterized phosphorylation antibodies in the Jak Stat pathway. Abnova 2 Pieces/Box 822 |
AA0032 |
Jak Stat II Phospho-Specific Array includes 202 highly specific and well-characterized phosphorylation antibodies in the Jak Stat pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0033 MAPK Phospho-Specific Array includes 185 highly specific and well-characterized phosphorylation antibodies in the MAPK pathway. Abnova 2 Pieces/Box 822 |
AA0033 |
MAPK Phospho-Specific Array includes 185 highly specific and well-characterized phosphorylation antibodies in the MAPK pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0034 mTOR Signalign Phospho-Specific Array includes 138 highly specific and well-characterized phosphorylation antibodies in the mTOR ignaling pathway. Abnova 2 Pieces/Box 776 |
AA0034 |
mTOR Signalign Phospho-Specific Array includes 138 highly specific and well-characterized phosphorylation antibodies in the mTOR ignaling pathway. |
Abnova |
2 Pieces/Box |
776€ |
|
Pub |
| AA0035 NF-kB Phospho-Specific Array includes 63 highly specific and well-characterized phosphorylation antibodies in the NF-kB pathway. Abnova 2 Pieces/Box 731 |
AA0035 |
NF-kB Phospho-Specific Array includes 63 highly specific and well-characterized phosphorylation antibodies in the NF-kB pathway. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0036 NF-kB II Phospho-Specific Array includes 215 highly specific and well-characterized phosphorylation antibodies in the NF-kB signaling pathway. Abnova 2 Pieces/Box 822 |
AA0036 |
NF-kB II Phospho-Specific Array includes 215 highly specific and well-characterized phosphorylation antibodies in the NF-kB signaling pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0038 p53 Signaling Phospho-Specific Array includes 196 highly specific and well-characterized phosphorylation antibodies in the p53 signaling pathway. Abnova 2 Pieces/Box 822 |
AA0038 |
p53 Signaling Phospho-Specific Array includes 196 highly specific and well-characterized phosphorylation antibodies in the p53 signaling pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0039 PDGF Phospho-Specific Array includes 195 highly specific and well-characterized phosphorylation antibodies in the PDGF pathway. Abnova 2 Pieces/Box 822 |
AA0039 |
PDGF Phospho-Specific Array includes 195 highly specific and well-characterized phosphorylation antibodies in the PDGF pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0040 T-Cell Receptor Signaling Phospho-Specific Array includes 188 highly specific and well-characterized phosphorylation antibodies in the T-cell receptor signaling pathway. Abnova 2 Pieces/Box 822 |
AA0040 |
T-Cell Receptor Signaling Phospho-Specific Array includes 188 highly specific and well-characterized phosphorylation antibodies in the T-cell receptor signaling pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0041 TGF-Beta Signaling Phospho-Specific Array includes 176 highly specific and well-characterized phosphorylation antibodies in the TGF-Beta signaling pathway. Abnova 2 Pieces/Box 822 |
AA0041 |
TGF-Beta Signaling Phospho-Specific Array includes 176 highly specific and well-characterized phosphorylation antibodies in the TGF-Beta signaling pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0017 Cell Cycle Control Phospho-Specific Array includes 238 highly specific and well-characterized phosphorylation antibodies in the regulation of cell cycle. Abnova 2 Pieces/Box 822 |
AA0017 |
Cell Cycle Control Phospho-Specific Array includes 238 highly specific and well-characterized phosphorylation antibodies in the regulation of cell cycle. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0023 EGF Phospho-Specific Array includes 214 highly specific and well-characterized phosphorylation antibodies related to the EGF family of proteins. Abnova 2 Pieces/Box 822 |
AA0023 |
EGF Phospho-Specific Array includes 214 highly specific and well-characterized phosphorylation antibodies related to the EGF family of proteins. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0037 Nuclear Membrane Receptors Phospho-Specific Array includes 52 highly specific and well-characterized phosphorylation antibodies related to Nuclear Membrane Receptors. Abnova 2 Pieces/Box 731 |
AA0037 |
Nuclear Membrane Receptors Phospho-Specific Array includes 52 highly specific and well-characterized phosphorylation antibodies related to Nuclear Membrane Receptors. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0042 Tyrosine Kinase Adaptors Phospho-Specific Array includes 98 highly specific and well-characterized phosphorylation antibodies related to Tyrosine Kinase Adaptors. Abnova 2 Pieces/Box 731 |
AA0042 |
Tyrosine Kinase Adaptors Phospho-Specific Array includes 98 highly specific and well-characterized phosphorylation antibodies related to Tyrosine Kinase Adaptors. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0046 Apoptosis (Human) Antibody Array (G) includes 43 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0046 |
Apoptosis (Human) Antibody Array (G) includes 43 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0068 Apoptosis (Human) Antibody Array includes 43 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0068 |
Apoptosis (Human) Antibody Array includes 43 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0004 Cell cycle antibody array includes 60 highly specific and well-characterized antibodies in the cell cycle pathway. Abnova 2 Pieces/Box 731 |
AA0004 |
Cell cycle antibody array includes 60 highly specific and well-characterized antibodies in the cell cycle pathway. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0005 Cytokine antibody array includes 77 highly specific and well-characterized antibodies in the cytokine pathway. Abnova 2 Pieces/Box 731 |
AA0005 |
Cytokine antibody array includes 77 highly specific and well-characterized antibodies in the cytokine pathway. |
Abnova |
2 Pieces/Box |
731€ |
|
Pub |
| AA0009 Signal transduction antibody array includes 165 highly specific and well-characterized antibodies in the signal transduction pathway. Abnova 2 Pieces/Box 822 |
AA0009 |
Signal transduction antibody array includes 165 highly specific and well-characterized antibodies in the signal transduction pathway. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| AA0043 Angiogenesis (Human) Antibody Array (G) includes 20 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0043 |
Angiogenesis (Human) Antibody Array (G) includes 20 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0044 Angiogenesis (Human) Antibody Array (G) includes 23 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0044 |
Angiogenesis (Human) Antibody Array (G) includes 23 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0045 Angiogenesis (Mouse) Antibody Array (G) includes 24 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0045 |
Angiogenesis (Mouse) Antibody Array (G) includes 24 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0047 Cytokine (Human) Antibody Array (G) includes 42 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0047 |
Cytokine (Human) Antibody Array (G) includes 42 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0048 Cytokine (Human) Antibody Array (G) includes 80 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0048 |
Cytokine (Human) Antibody Array (G) includes 80 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
| AA0049 Cytokine (Human) Antibody Array (G) includes 60 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0049 |
Cytokine (Human) Antibody Array (G) includes 60 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
| AA0050 Cytokine (Human) Antibody Array (G) includes 60 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0050 |
Cytokine (Human) Antibody Array (G) includes 60 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
| AA0051 Cytokine (Human) Antibody Array (G) includes 54 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0051 |
Cytokine (Human) Antibody Array (G) includes 54 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
| AA0052 Cytokine (Human) Antibody Array (G) includes 51 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0052 |
Cytokine (Human) Antibody Array (G) includes 51 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
| AA0053 Cytokine (Human) Antibody Array (G) includes 49 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0053 |
Cytokine (Human) Antibody Array (G) includes 49 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
| AA0054 Cytokine (Mouse) Antibody Array (G) includes 32 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0054 |
Cytokine (Mouse) Antibody Array (G) includes 32 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0055 Cytokine (Mouse) Antibody Array (G) includes 62 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0055 |
Cytokine (Mouse) Antibody Array (G) includes 62 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
| AA0056 Cytokine (Mouse) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0056 |
Cytokine (Mouse) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0057 Cytokine (Mouse) Antibody Array (G) includes 48 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0057 |
Cytokine (Mouse) Antibody Array (G) includes 48 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0058 Cytokine (Mouse) Antibody Array (G) includes 97 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 1323 |
AA0058 |
Cytokine (Mouse) Antibody Array (G) includes 97 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
1323€ |
|
Pub |
| AA0059 Cytokine (Rat) Antibody Array (G) includes 19 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0059 |
Cytokine (Rat) Antibody Array (G) includes 19 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0060 Cytokine (Rat) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0060 |
Cytokine (Rat) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0061 Inflammation (Human) Antibody Array (G) includes 40 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0061 |
Inflammation (Human) Antibody Array (G) includes 40 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0062 Inflammation (Mouse) Antibody Array (G) includes 40 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0062 |
Inflammation (Mouse) Antibody Array (G) includes 40 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0063 Obesity (Human) Antibody Array (G) includes 62 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0063 |
Obesity (Human) Antibody Array (G) includes 62 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
| AA0064 Th1 Th2 Th17 (Human) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0064 |
Th1 Th2 Th17 (Human) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
| AA0065 Angiogenesis (Human) Antibody Array includes 20 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0065 |
Angiogenesis (Human) Antibody Array includes 20 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0066 Angiogenesis (Human) Antibody Array includes 23 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0066 |
Angiogenesis (Human) Antibody Array includes 23 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0067 Angiogenesis (Mouse) Antibody Array includes 24 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0067 |
Angiogenesis (Mouse) Antibody Array includes 24 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0069 Atherosclerosis (Human) Antibody Array includes 20 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0069 |
Atherosclerosis (Human) Antibody Array includes 20 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0070 Atherosclerosis (Mouse) Antibody Array includes 22 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0070 |
Atherosclerosis (Mouse) Antibody Array includes 22 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0071 Chemokine (Human) Antibody Array includes 38 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0071 |
Chemokine (Human) Antibody Array includes 38 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0072 Cytokine (Human) Antibody Array includes 23 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0072 |
Cytokine (Human) Antibody Array includes 23 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0073 Cytokine (Human) Antibody Array includes 42 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0073 |
Cytokine (Human) Antibody Array includes 42 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0074 Cytokine (Human) Antibody Array includes 36 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0074 |
Cytokine (Human) Antibody Array includes 36 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0075 Cytokine (Human) Antibody Array includes 80 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0075 |
Cytokine (Human) Antibody Array includes 80 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0076 Cytokine (Human) Antibody Array includes 60 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0076 |
Cytokine (Human) Antibody Array includes 60 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0077 Cytokine (Human) Antibody Array includes 60 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0077 |
Cytokine (Human) Antibody Array includes 60 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0078 Cytokine (Human) Antibody Array includes 54 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0078 |
Cytokine (Human) Antibody Array includes 54 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0079 Cytokine (Human) Antibody Array includes 51 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0079 |
Cytokine (Human) Antibody Array includes 51 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0080 Cytokine (Human) Antibody Array includes 49 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0080 |
Cytokine (Human) Antibody Array includes 49 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0081 Cytokine (Mouse) Antibody Array includes 22 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0081 |
Cytokine (Mouse) Antibody Array includes 22 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0082 Cytokine (Mouse) Antibody Array includes 32 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0082 |
Cytokine (Mouse) Antibody Array includes 32 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0083 Cytokine (Mouse) Antibody Array includes 62 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0083 |
Cytokine (Mouse) Antibody Array includes 62 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0084 Cytokine (Mouse) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0084 |
Cytokine (Mouse) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0085 Cytokine (Mouse) Antibody Array includes 48 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0085 |
Cytokine (Mouse) Antibody Array includes 48 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0086 Cytokine (Mouse) Antibody Array includes 97 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 1456 |
AA0086 |
Cytokine (Mouse) Antibody Array includes 97 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
1456€ |
|
Pub |
| AA0087 Cytokine (Rat) Antibody Array includes 19 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0087 |
Cytokine (Rat) Antibody Array includes 19 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0088 Cytokine (Rat) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0088 |
Cytokine (Rat) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0089 Growth Factor (Human) Antibody Array includes 41 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0089 |
Growth Factor (Human) Antibody Array includes 41 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0090 Inflammation (Human) Antibody Array includes 20 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0090 |
Inflammation (Human) Antibody Array includes 20 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0091 Inflammation (Human) Antibody Array includes 20 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0091 |
Inflammation (Human) Antibody Array includes 20 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0092 Inflammation (Human) Antibody Array includes 40 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0092 |
Inflammation (Human) Antibody Array includes 40 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0093 Inflammation (Mouse) Antibody Array includes 40 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0093 |
Inflammation (Mouse) Antibody Array includes 40 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0094 MMP (Human) Antibody Array includes 10 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0094 |
MMP (Human) Antibody Array includes 10 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| AA0095 Obesity (Human) Antibody Array includes 62 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 888 |
AA0095 |
Obesity (Human) Antibody Array includes 62 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
888€ |
|
Pub |
| AA0096 Th1 Th2 Th17 (Human) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0096 |
Th1 Th2 Th17 (Human) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
| MC961 Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 US Biomax 231 |
MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 |
US Biomax |
|
231€ |
|
Pub |
| AA0008 Master antibody array is a comprehensive array consisting of 656 highly specific and well-characterized antibodies. Abnova 2 Pieces/Box 822 |
AA0008 |
Master antibody array is a comprehensive array consisting of 656 highly specific and well-characterized antibodies. |
Abnova |
2 Pieces/Box |
822€ |
|
Pub |
| MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266 |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 |
US Biomax |
|
266€ |
|
Pub |
| PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed US Biomax 296 |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed |
US Biomax |
|
296€ |
|
Pub |
| BC001128 Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores US Biomax 485 |
BC001128 |
Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores |
US Biomax |
|
485€ |
|
Pub |
| BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
| BC04011 Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed US Biomax 185 |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
185€ |
|
Pub |
| BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296 |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC051110 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
| BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC051111 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
| BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 US Biomax 231 |
BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 |
US Biomax |
|
231€ |
|
Pub |
| BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
BC05118 |
Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296 |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321 |
BC06002 |
Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores |
US Biomax |
|
321€ |
|
Pub |
| BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321 |
BC07001 |
Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores |
US Biomax |
|
321€ |
|
Pub |
| BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
| BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 US Biomax 278 |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 |
US Biomax |
|
278€ |
|
Pub |
| BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores US Biomax 278 |
BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores |
US Biomax |
|
278€ |
|
Pub |
| BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 US Biomax 266 |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 |
US Biomax |
|
266€ |
|
Pub |
| BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 US Biomax 231 |
BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 |
US Biomax |
|
231€ |
|
Pub |
| BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
| BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111109 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
| BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
| BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
| BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores US Biomax 266 |
BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
| BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 US Biomax 266 |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 |
US Biomax |
|
266€ |
|
Pub |
| BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BL1002 |
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| BL1921 Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
BL1921 |
Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
| BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
BL242 |
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
| BL482 Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
BL482 |
Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| BL805 Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
BL805 |
Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 US Biomax 266 |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 |
US Biomax |
|
266€ |
|
Pub |
| BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a US Biomax 88 |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a |
US Biomax |
|
88€ |
|
Pub |
| BR042a Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores US Biomax 88 |
BR042a |
Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores |
US Biomax |
|
88€ |
|
Pub |
| BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores US Biomax 112 |
BR082 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores |
US Biomax |
|
112€ |
|
Pub |
| BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 US Biomax 314 |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 |
US Biomax |
|
314€ |
|
Pub |
| BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296 |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme |
US Biomax |
|
296€ |
|
Pub |
| BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296 |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 US Biomax 266 |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 |
US Biomax |
|
266€ |
|
Pub |
| BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278 |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 |
US Biomax |
|
278€ |
|
Pub |
| BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296 |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- |
US Biomax |
|
296€ |
|
Pub |
| BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296 |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin |
US Biomax |
|
296€ |
|
Pub |
| BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
BR1922 |
Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
| BR2083 High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456 |
BR2083 |
High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| BR2085a High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c. US Biomax 456 |
BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c. |
US Biomax |
|
456€ |
|
Pub |
| BR2085b High density (188 cases 208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast US Biomax 456 |
BR2085b |
High density (188 cases 208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast |
US Biomax |
|
456€ |
|
Pub |
| BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456 |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a |
US Biomax |
|
456€ |
|
Pub |
| BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456 |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 |
US Biomax |
|
456€ |
|
Pub |
| BR2161 Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
BR2161 |
Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
| BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90 |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90 |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| BR244 Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245 US Biomax 88 |
BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245 |
US Biomax |
|
88€ |
|
Pub |
| BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88 |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a |
US Biomax |
|
88€ |
|
Pub |
| BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide US Biomax 189 |
BR247 |
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide |
US Biomax |
|
189€ |
|
Pub |
| BR482 Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info US Biomax 160 |
BR482 |
Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
| BR484 Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
BR484 |
Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
| BR485 Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
BR485 |
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
| BR722 Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages US Biomax 231 |
BR722 |
Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages |
US Biomax |
|
231€ |
|
Pub |
| BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 US Biomax 231 |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 |
US Biomax |
|
231€ |
|
Pub |
| BR8012 Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014 US Biomax 231 |
BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014 |
US Biomax |
|
231€ |
|
Pub |
| BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores US Biomax 231 |
BR8013 |
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231 |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 |
US Biomax |
|
231€ |
|
Pub |
| BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231 |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 |
US Biomax |
|
231€ |
|
Pub |
| BR8016 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
BR8016 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| BR8017 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
BR8017 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
| BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
| BRC711 Human breast invasive ductal cancer tissue array, non overlapping with BRC491, 71 cases 72 cores US Biomax 142 |
BRC711 |
Human breast invasive ductal cancer tissue array, non overlapping with BRC491, 71 cases 72 cores |
US Biomax |
|
142€ |
|
Pub |
| BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258 |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| CLC601 Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores US Biomax 266 |
CLC601 |
Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores |
US Biomax |
|
266€ |
|
Pub |
| CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores US Biomax 314 |
CNS801 |
Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores |
US Biomax |
|
314€ |
|
Pub |
| CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 |
CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| CO2001 Colon cancer high density tissue array, including TNM and pathology grade, 196 cases 200 core US Biomax 397 |
CO2001 |
Colon cancer high density tissue array, including TNM and pathology grade, 196 cases 200 core |
US Biomax |
|
397€ |
|
Pub |
| CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456 |
CO2081 |
Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO20810 |
Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CO2083 High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456 |
CO2083 |
High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2087 |
Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2088 |
Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2089 |
Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CO2161 Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
CO2161 |
Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
| CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105 |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
| CO244 Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
CO244 |
Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| CO483 Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade information US Biomax 160 |
CO483 |
Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade information |
US Biomax |
|
160€ |
|
Pub |
| CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210 |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
| CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
CO485 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
| CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
CO486 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
| CO701 Colon cancer tissue array, with grade 1 4 and normal colon tissue, 70 cases 70 cores, with stage and grade information US Biomax 231 |
CO701 |
Colon cancer tissue array, with grade 1 4 and normal colon tissue, 70 cases 70 cores, with stage and grade information |
US Biomax |
|
231€ |
|
Pub |
| CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 US Biomax 266 |
CO702 |
Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 |
US Biomax |
|
266€ |
|
Pub |
| CO721 Colon cancer tissue array with stage and grade info, 24 cases 72 cores US Biomax 231 |
CO721 |
Colon cancer tissue array with stage and grade info, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
| CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258 |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267 |
CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
| CO807 Advanced colon cancer tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266 |
CO807 |
Advanced colon cancer tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
CR1003 |
Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
| CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| CR1921 Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
CR1921 |
Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
| CR2081 High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores US Biomax 456 |
CR2081 |
High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CR2082 High density cervical cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456 |
CR2082 |
High density cervical cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2083 |
Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2084 |
Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2085 |
Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CR2087 Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2087 |
Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CR2088 |
Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CR2089 Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CR2089 |
Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| CR243 Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide US Biomax 160 |
CR243 |
Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide |
US Biomax |
|
160€ |
|
Pub |
| CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 US Biomax 189 |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 |
US Biomax |
|
189€ |
|
Pub |
| CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
| CR485 Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
CR485 |
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
| CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231 |
CR602 |
Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 |
US Biomax |
|
231€ |
|
Pub |
| CR805 Cervix cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
CR805 |
Cervix cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| CR806 Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
CR806 |
Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| EM1021 Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases 102 cores US Biomax 314 |
EM1021 |
Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases 102 cores |
US Biomax |
|
314€ |
|
Pub |
| EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
ES1001 |
Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
ES1002 |
Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| ES1921 Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
ES1921 |
Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
| ES2082 High density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases 208 cores US Biomax 456 |
ES2082 |
High density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| ES243 Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
ES243 |
Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed US Biomax 210 |
ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
| ES483 Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 189 |
ES483 |
Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| ES721 Esophagus cancer and normal tissue array with TNM and grade info, 24 cases 72 cores US Biomax 231 |
ES721 |
Esophagus cancer and normal tissue array with TNM and grade info, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
| ES722 Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 US Biomax 231 |
ES722 |
Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 |
US Biomax |
|
231€ |
|
Pub |
| ES781 Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 US Biomax 266 |
ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 |
US Biomax |
|
266€ |
|
Pub |
| ES8010 Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801 US Biomax 231 |
ES8010 |
Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801 |
US Biomax |
|
231€ |
|
Pub |
| ES8011 Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores US Biomax 231 |
ES8011 |
Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| ES8012 Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 278 |
ES8012 |
Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
| ES807 Esophageal cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
ES807 |
Esophageal cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| ES808 Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases 80 cores US Biomax 231 |
ES808 |
Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| ES811 Esophageal cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, plus grade and stage information US Biomax 231 |
ES811 |
Esophageal cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, plus grade and stage information |
US Biomax |
|
231€ |
|
Pub |
| FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
| FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
| FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
| FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 278 |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
278€ |
|
Pub |
| FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 314 |
FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
314€ |
|
Pub |
| FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 US Biomax 278 |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 |
US Biomax |
|
278€ |
|
Pub |
| FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 380 |
FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
380€ |
|
Pub |
| FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| FDA997 FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 US Biomax 314 |
FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 |
US Biomax |
|
314€ |
|
Pub |
| FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed US Biomax 394 |
FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
| FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed US Biomax 626 |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
| FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626 |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
| FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed US Biomax 626 |
FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
| FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
| FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331 |
FMC407 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
331€ |
|
Pub |
| FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed US Biomax 626 |
FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
| FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 |
FMC408 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
| GI961 GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores US Biomax 231 |
GI961 |
GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores |
US Biomax |
|
231€ |
|
Pub |
| HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90 |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 US Biomax 160 |
HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 |
US Biomax |
|
160€ |
|
Pub |
| HN803 Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
HN803 |
Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
KD1001 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
| KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
KD1002 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
| KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD1501 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| KD1921 Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
KD1921 |
Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
| KD20810 Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20810 |
Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD20811 Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20811 |
Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD20812 Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20812 |
Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD2082 High density kidney cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores US Biomax 456 |
KD2082 |
High density kidney cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD2083 Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456 |
KD2083 |
Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2085 |
Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2086 |
Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2087 |
Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2088 |
Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD2089 Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2089 |
Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| KD243 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
KD243 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| KD484 Kidney cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
KD484 |
Kidney cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| KD485 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
KD485 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| KD804 Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases 80 cores, with stage and grade information US Biomax 231 |
KD804 |
Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases 80 cores, with stage and grade information |
US Biomax |
|
231€ |
|
Pub |
| KD806 Advanced kidney cancer tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
KD806 |
Advanced kidney cancer tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| KD808 Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231 |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| LC10012 Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 US Biomax 266 |
LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 |
US Biomax |
|
266€ |
|
Pub |
| LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC1502 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC20810 |
Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC20811 |
Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20812 |
Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC20813 Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20813 |
Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC20814 Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20814 |
Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC20815 Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20815 |
Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC20816 Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20816 |
Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC2084 High density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores US Biomax 456 |
LC2084 |
High density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC2085b High density (208 cores), multiple types of lung cancer (grade 1 3) tissue array with normal lung and cancer adjacent tissue, and staging info, 188 cases 208 cores (duplicate of LC2085a) US Biomax 456 |
LC2085b |
High density (208 cores), multiple types of lung cancer (grade 1 3) tissue array with normal lung and cancer adjacent tissue, and staging info, 188 cases 208 cores (duplicate of LC2085a) |
US Biomax |
|
456€ |
|
Pub |
| LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC2088 |
Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC2089 |
Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LC2161 Lung cancer tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
LC2161 |
Lung cancer tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
| LC243 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
LC243 |
Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| LC484 Lung cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
LC484 |
Lung cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
| LC485 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
LC485 |
Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| LC486 Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 188 |
LC486 |
Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
188€ |
|
Pub |
| LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
LC488 |
Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
| LC723 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071 US Biomax 231 |
LC723 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071 |
US Biomax |
|
231€ |
|
Pub |
| LC724 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031 US Biomax 231 |
LC724 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031 |
US Biomax |
|
231€ |
|
Pub |
| LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
| LC807 Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014 US Biomax 231 |
LC807 |
Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014 |
US Biomax |
|
231€ |
|
Pub |
| LC815 Lung cancer and normal tissue array with stage and grade info, 40 cases 80 cores US Biomax 231 |
LC815 |
Lung cancer and normal tissue array with stage and grade info, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| LC816 Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases 80 cores US Biomax 231 |
LC816 |
Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC961 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| LP208 High density larynx and pharynx cancer tissue array with normal tissue (69 cases 208 core) including stage and grade data US Biomax 456 |
LP208 |
High density larynx and pharynx cancer tissue array with normal tissue (69 cases 208 core) including stage and grade data |
US Biomax |
|
456€ |
|
Pub |
| LP721 Laryngeal cancer and normal tissue array, with grade and TNM information, 24 cases 72 cores US Biomax 266 |
LP721 |
Laryngeal cancer and normal tissue array, with grade and TNM information, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
| LP804 Laryngeal cancerous, cancer adjacent and normal tissue array, with grade and stage info, 40 cases 80 cores US Biomax 266 |
LP804 |
Laryngeal cancerous, cancer adjacent and normal tissue array, with grade and stage info, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LV1001 |
Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
| LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
LV1002 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
| LV1003 Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 cores US Biomax 314 |
LV1003 |
Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
314€ |
|
Pub |
| LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
LV1502 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| LV20810 Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV20810 |
Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV20811 Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV20811 |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV20812 Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 cores US Biomax 456 |
LV20812 |
Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV2082 Liver cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores US Biomax 456 |
LV2082 |
Liver cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV2083 High density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456 |
LV2083 |
High density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516 |
LV2084 |
Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
516€ |
|
Pub |
| LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2085 |
Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2086 |
Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2087 |
Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2088 |
Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV2089 Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV2089 |
Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429 |
LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
| LV2161 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
LV2161 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
| LV244 Liver cancer tissue array, with stage and grade info, 8 cases 24 cores US Biomax 88 |
LV244 |
Liver cancer tissue array, with stage and grade info, 8 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| LV245 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
LV245 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
LV484 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
| LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
LV485 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
| LV486 Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 231 |
LV486 |
Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
| LV723 Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 US Biomax 231 |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 |
US Biomax |
|
231€ |
|
Pub |
| LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011 US Biomax 231 |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011 |
US Biomax |
|
231€ |
|
Pub |
| LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296 |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| LV8012 Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231 |
LV8012 |
Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| LV808 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
LV808 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| LVC482 Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC481, 16 cases 48 cores US Biomax 166 |
LVC482 |
Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC481, 16 cases 48 cores |
US Biomax |
|
166€ |
|
Pub |
| LVC961 Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC962, 48 cases 96 cores US Biomax 189 |
LVC961 |
Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC962, 48 cases 96 cores |
US Biomax |
|
189€ |
|
Pub |
| MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88 |
MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 |
US Biomax |
|
88€ |
|
Pub |
| MC5001 High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002 US Biomax 634 |
MC5001 |
High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002 |
US Biomax |
|
634€ |
|
Pub |
| MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 |
MC601 |
Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
| MC641 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 US Biomax 0 |
MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 |
US Biomax |
|
0€ |
|
Pub |
| MC801 Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information US Biomax 266 |
MC801 |
Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information |
US Biomax |
|
266€ |
|
Pub |
| MC8010 Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 278 |
MC8010 |
Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
| MC802 Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information US Biomax 266 |
MC802 |
Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information |
US Biomax |
|
266€ |
|
Pub |
| MC807 Multiple types of cancer tissue array, with stage and TNM information, 40 cases 80 cores US Biomax 278 |
MC807 |
Multiple types of cancer tissue array, with stage and TNM information, 40 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
| MD-14-1047 Rabbit Anti-Human Apoptosis Inhibitor of Macrophages (AIM) Antibodies Ray Biotech 100 502 |
MD-14-1047 |
Rabbit Anti-Human Apoptosis Inhibitor of Macrophages (AIM) Antibodies |
Ray Biotech |
100 |
502€ |
|
Pub |
| MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
MGS801 |
Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258 |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
OV1003 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
| OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
OV1004 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
| OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 |
OV1005 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 |
US Biomax |
|
266€ |
|
Pub |
| OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
| OV20810 Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20810 |
Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV20811 Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20811 |
Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV20812 Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20812 |
Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV20813 Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20813 |
Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV2082 Ovary cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores US Biomax 456 |
OV2082 |
Ovary cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV2083 High density ovarian cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456 |
OV2083 |
High density ovarian cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2085 |
Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2086 |
Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2087 |
Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2088 |
Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2089 |
Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105 |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
| OV243 Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
OV243 |
Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| OV482 Multiple ovarian cancer tissue array with 4 normal tissues control from autopsy, (24 cases 48 cores) with grade and stage info US Biomax 160 |
OV482 |
Multiple ovarian cancer tissue array with 4 normal tissues control from autopsy, (24 cases 48 cores) with grade and stage info |
US Biomax |
|
160€ |
|
Pub |
| OV483 Multiple ovarian cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info US Biomax 160 |
OV483 |
Multiple ovarian cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
| OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
OV484 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
| OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
OV485 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
| OV6161 High density ovarian cancer array, with stage and grade information, 322 cases 616 cores US Biomax 753 |
OV6161 |
High density ovarian cancer array, with stage and grade information, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
| OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
| OV8010 Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
OV8010 |
Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| OV809 Ovary cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266 |
OV809 |
Ovary cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| PA1002 Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
PA1002 |
Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| PA1003 Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases 100 cores US Biomax 314 |
PA1003 |
Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases 100 cores |
US Biomax |
|
314€ |
|
Pub |
| PA1921 Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
PA1921 |
Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
| PA2072 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 US Biomax 456 |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 |
US Biomax |
|
456€ |
|
Pub |
| PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores US Biomax 456 |
PA2081 |
Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| PA2082 High density pancreatic cancer and normal tissue array, with stage and grade info, 101 cases 208 cores US Biomax 456 |
PA2082 |
High density pancreatic cancer and normal tissue array, with stage and grade info, 101 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
| PA243 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
PA243 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed US Biomax 185 |
PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
| PA801 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802 US Biomax 231 |
PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802 |
US Biomax |
|
231€ |
|
Pub |
| PA804 Pancreatic cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266 |
PA804 |
Pancreatic cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 US Biomax 266 |
PA805 |
Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 |
US Biomax |
|
266€ |
|
Pub |
| PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278 |
PA961 |
Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores |
US Biomax |
|
278€ |
|
Pub |
| PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258 |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114 |
PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed |
US Biomax |
|
114€ |
|
Pub |
| PR1001 Prostate cancer tissue array, including TNM and pathology grade, 25 cases 100 cores US Biomax 266 |
PR1001 |
Prostate cancer tissue array, including TNM and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
| PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105 |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
| PR243 Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241 US Biomax 88 |
PR243 |
Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241 |
US Biomax |
|
88€ |
|
Pub |
| PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105 |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
| PR483 Multiple prostate cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage, grade and Gleason score info US Biomax 160 |
PR483 |
Multiple prostate cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage, grade and Gleason score info |
US Biomax |
|
160€ |
|
Pub |
| PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
| PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 |
PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
| PR632 Prostate cancer, hyperplasia with normal tissue array, with Gleason scores and stage information, 21cases 63 cores US Biomax 266 |
PR632 |
Prostate cancer, hyperplasia with normal tissue array, with Gleason scores and stage information, 21cases 63 cores |
US Biomax |
|
266€ |
|
Pub |
| PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| PR751 Prostate cancer, PIN (prostatic intraepithelial neoplasia) and hyperplasia tissue array, 75 cases 75 cores, with grade and Gleason's Score data US Biomax 266 |
PR751 |
Prostate cancer, PIN (prostatic intraepithelial neoplasia) and hyperplasia tissue array, 75 cases 75 cores, with grade and Gleason's Score data |
US Biomax |
|
266€ |
|
Pub |
| PR752 Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases 75 cores US Biomax 266 |
PR752 |
Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases 75 cores |
US Biomax |
|
266€ |
|
Pub |
| PR753 Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases 75 cores US Biomax 266 |
PR753 |
Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases 75 cores |
US Biomax |
|
266€ |
|
Pub |
| PR8010 Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802 US Biomax 266 |
PR8010 |
Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802 |
US Biomax |
|
266€ |
|
Pub |
| PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| PR807 Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases 80 cores US Biomax 266 |
PR807 |
Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| PR808 Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012 US Biomax 266 |
PR808 |
Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012 |
US Biomax |
|
266€ |
|
Pub |
| RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 |
RE1021 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
| RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
RE1503 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
| RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 |
RE601 |
Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
| RE722 Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022 US Biomax 231 |
RE722 |
Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022 |
US Biomax |
|
231€ |
|
Pub |
| RE803 Rectal cancer and normal tissue array, with TNM and grade info, 73 cases 80 cores US Biomax 231 |
RE803 |
Rectal cancer and normal tissue array, with TNM and grade info, 73 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| SK721 Skin cancer and normal tissue array, with stage and grade info, 24 cases 72 cores US Biomax 266 |
SK721 |
Skin cancer and normal tissue array, with stage and grade info, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
| SK804 Skin cancerous and normal tissue array, with stage and grade info, 40 cases 80 cores US Biomax 266 |
SK804 |
Skin cancerous and normal tissue array, with stage and grade info, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| SM2081 Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores US Biomax 456 |
SM2081 |
Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266 |
SM802 |
Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
| SO481 Soft tissue cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with TNM information US Biomax 160 |
SO481 |
Soft tissue cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with TNM information |
US Biomax |
|
160€ |
|
Pub |
| SO482 Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
SO482 |
Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| SO8012 Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 40 cases 80 cores US Biomax 278 |
SO8012 |
Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 40 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
| ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
ST1003 |
Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
| ST1921 Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
ST1921 |
Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
| ST2001 Stomach cancer high density (200 cases 200 cores) tissue array, including TNM and pathology grade US Biomax 397 |
ST2001 |
Stomach cancer high density (200 cases 200 cores) tissue array, including TNM and pathology grade |
US Biomax |
|
397€ |
|
Pub |
| ST2082 High density stomach cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores US Biomax 456 |
ST2082 |
High density stomach cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
| ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487 |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed |
US Biomax |
|
487€ |
|
Pub |
| ST481 Stomach cancer tissue array with corresponding (self matching) normal adjacent tissues (12 cases 48 cores), with stage and grade info US Biomax 160 |
ST481 |
Stomach cancer tissue array with corresponding (self matching) normal adjacent tissues (12 cases 48 cores), with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
| ST482 Multiple stomach cancer tissue array with 4 normal tissues control from autopsy (24 caeas 48 cores), with stage and grade info US Biomax 160 |
ST482 |
Multiple stomach cancer tissue array with 4 normal tissues control from autopsy (24 caeas 48 cores), with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
| ST483 Multiple stomach cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info US Biomax 160 |
ST483 |
Multiple stomach cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
| ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
| ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210 |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
| ST484 Stomach cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
ST484 |
Stomach cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| ST485 Stomach cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 189 |
ST485 |
Stomach cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
| ST8014 Stomach cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
ST8014 |
Stomach cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| ST8015 Stomach cancer and adjacent normal tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231 |
ST8015 |
Stomach cancer and adjacent normal tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267 |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
| ST805 Stomach cancer progression tissue array (containing normal, inflammation, hyperplasia and adenocarcinoma), 80 cases 80 cores US Biomax 231 |
ST805 |
Stomach cancer progression tissue array (containing normal, inflammation, hyperplasia and adenocarcinoma), 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231 |
ST812 |
Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
| ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
ST962 |
Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
| STC1021 Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases 102 cores US Biomax 225 |
STC1021 |
Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases 102 cores |
US Biomax |
|
225€ |
|
Pub |
| T0010 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0010 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T0011 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0011 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T0012 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0012 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T0013 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0013 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T0014 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0014 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T002 Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88 |
T002 |
Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T003 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T003 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T004 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T004 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T005 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T005 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T006 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T006 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T007 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T007 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T008 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T008 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T009 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T009 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T011 Stomach cancer test tissue array, with TNM and grade info, 6 cases 24 cores US Biomax 88 |
T011 |
Stomach cancer test tissue array, with TNM and grade info, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T012 Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T012 |
Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T013 Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T013 |
Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T021 Esophageal cancer tissue array, with normal tissues, TNM and grade info, 6 cases 24 cores US Biomax 88 |
T021 |
Esophageal cancer tissue array, with normal tissues, TNM and grade info, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T022 Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T022 |
Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T031 Liver cancer test tissue array with normal liver tissues, with TNM, stage and grade info, 6 cases 24 cores US Biomax 88 |
T031 |
Liver cancer test tissue array with normal liver tissues, with TNM, stage and grade info, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T032 |
Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T033 Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T033 |
Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T034 |
Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T041 Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T041 |
Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 US Biomax 88 |
T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 |
US Biomax |
|
88€ |
|
Pub |
| T043 Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T043 |
Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 US Biomax 88 |
T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 |
US Biomax |
|
88€ |
|
Pub |
| T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b US Biomax 88 |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b |
US Biomax |
|
88€ |
|
Pub |
| T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99 |
T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 |
US Biomax |
|
99€ |
|
Pub |
| T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90 |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T046 |
Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T051 Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T051 |
Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T052 Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T052 |
Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T053 Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T053 |
Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90 |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T061 Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T061 |
Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T063 Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T063 |
Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T071 |
Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T073 Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T073 |
Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 US Biomax 88 |
T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 |
US Biomax |
|
88€ |
|
Pub |
| T082 Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 US Biomax 88 |
T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 |
US Biomax |
|
88€ |
|
Pub |
| T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T083 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 US Biomax 88 |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 |
US Biomax |
|
88€ |
|
Pub |
| T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 US Biomax 88 |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 |
US Biomax |
|
88€ |
|
Pub |
| T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90 |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90 |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 US Biomax 88 |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 |
US Biomax |
|
88€ |
|
Pub |
| T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T091 Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T091 |
Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T092 Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T092 |
Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T093 Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T093 |
Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T101 Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T101 |
Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T102 Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T102 |
Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T103 Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T103 |
Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T111 Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T111 |
Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T112 Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T112 |
Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90 |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T113 Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T113 |
Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90 |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
| T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T121 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T122 |
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T123 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
| T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
